UnitedHealth
UNH
Market cap $276B

304.10 USD

+4.59

1.53%

At close Jul 11, 4:00 PM EDT

After hours

303.11

-0.99

0.33%

1 day

1.53%

5 days

-1.27%

1 month

-2.08%

3 months

-49.27%

6 months

-43.80%

Year to date

-39.72%

1 year

-39.71%

5 years

1.46%

10 years

148.35%

About: UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Employees: 400,000

Healthcare Healthcare Plans

0

Funds holding %

of 7,312 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

17% more call options, than puts

Call options by funds: $5.97B | Put options by funds: $5.11B

11% more funds holding in top 10

Funds holding in top 10: 198 [Q4 2024] → 220 (+22) [Q1 2025]

1% more capital invested

Capital invested by funds: $413B [Q4 2024] → $416B (+$3.81B) [Q1 2025]

0.7% less ownership

Funds ownership: 87.65% [Q4 2024] → 86.95% (-0.7%) [Q1 2025]

5% less first-time investments, than exits

New positions opened: 203 | Existing positions closed: 213

3% less funds holding

Funds holding: 3,616 [Q4 2024] → 3,525 (-91) [Q1 2025]

15% less repeat investments, than reductions

Existing positions increased: 1,379 | Existing positions reduced: 1,628

See Fund Rankings

Research analyst outlook

19 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$270

11%

downside

Avg. target

$378

24%

upside

High target

$575

89%

upside

19 analyst ratings

15 positive

79%

3 neutral

16%

1 negative

5%

Barclays Andrew Mok	11%upside $337	Overweight Maintained	9 Jul 2025
UBS Kevin Caliendo	27%upside $385	Buy Maintained	25 Jun 2025
JP Morgan Lisa Gill	37%upside $418	Overweight Maintained	20 Jun 2025
Baird Michael Ha	3%upside $312	Neutral Downgraded	11 Jun 2025
Piper Sandler Jessica Tassan	16%upside $353	Overweight Maintained	3 Jun 2025

See Analyst Rankings

Financial journalist opinion

Based on 86 articles about UNH published over the past 30 days

3 Stocks to Buy Ahead of the Upcoming Earnings Season

Next week marks the beginning of another earnings season. This is a time when stocks can move sharply as investors process and act on a company's results and guidance.

3 Stocks to Buy Ahead of the Upcoming Earnings Season

Zacks Investment Research

UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?

CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.

UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?

Zacks Investment Research

Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?

Zacks Investment Research

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

UnitedHealth Hits Reset: New Head Of Medicaid Appointed As CEO Reshapes Team

UnitedHealth Group, Inc. UNH appointed a new head of its Medicaid division, a position that had been unfilled since May.

UnitedHealth Hits Reset: New Head Of Medicaid Appointed As CEO Reshapes Team

Zacks Investment Research

Billing or Healing? UnitedHealth's HouseCalls Get a DOJ Checkup

UNH faces a DOJ criminal probe over its HouseCalls billing, raising stakes for the Medicare Advantage giant.

Billing or Healing? UnitedHealth's HouseCalls Get a DOJ Checkup

UnitedHealth's Q2 Could Get Messy: Will July 29 Bring Answers?

UnitedHealth Group Incorporated faces significant uncertainty due to an active DOJ investigation and ongoing Medicare Advantage margin pressures, clouding near-term prospects. UNH Q1 earnings disappointed across all metrics, with management withdrawing guidance, highlighting operational challenges and lack of visibility. Insider buying has surged, signaling some internal confidence, while the stock trades at historically cheap valuations if issues prove temporary.

UnitedHealth's Q2 Could Get Messy: Will July 29 Bring Answers?

The Motley Fool

2 High-Yield Dividend Growth Stocks to Buy Now and Hold for Decades

If you're an income-seeking investor, a buoyant stock market near its all-time high is actually a problem. At recent prices, the average stock in the benchmark S&P 500 index offers an itty-bitty 1.2% dividend yield.

2 High-Yield Dividend Growth Stocks to Buy Now and Hold for Decades

DOJ questions ex-UnitedHealth doctors in probe into Medicare fraud: report

The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain diagnoses that trigger higher payments under Medicare Advantage, according to a report.

DOJ questions ex-UnitedHealth doctors in probe into Medicare fraud: report

CNBC Television

Final Trades: Wabtec, UnitedHealth and DoorDash

The Investment Committee give you their top stocks to watch for the second half.

Final Trades: Wabtec, UnitedHealth and DoorDash

See News Rankings

Charts implemented using Lightweight Charts™